The hazard ratio (HR) for the primary endpoint was (3.84, p = 0.0009) in the first month
The Prolocor pFCG™ test has the potential to help providers reduce 30-day readmission rates for Acute MI, an important criterion for CMS penalties.
Mentavi's innovative online asynchronous assessment, validated in a clinical study presented at the 10th World Congress on ADHD, provides clinicians with an efficient, comprehensive diagnostic mental health evaluation at an affordable price for their patients.
Read More
Mentavi, a national leader in online mental health testing, will attend the 10th World Congress on ADHD and present a first-ever study comparing the accuracy and validity of an online asynchronous assessment for diagnosing ADHD in adults with the current standard of care, a clinical interview.
Read More
Despite differences in characteristics and treatment, the pFCG test distinguished risk of the primary ischemic endpoint to a similar extent in the 2 groups.
No significant association was observed between pFCG and risk of bleeding.
Date: March 31, 2025, 10:36 A.M.
Location: Moderated Poster Theater 7
PROGNOSTIC IMPLICATIONS OF PLATELET FCɣRIIA DURING THE FIRST YEAR AFTER MYOCARDIAL INFARCTION
Read MoreNew partnership will deliver convenient, at-home X-ray and ultrasound services to over 60,000 Medicare Advantage members in Illinois, Missouri, Ohio, Kentucky and Indiana
Read More
Liom, formerly known as Spiden, a pioneer in non-invasive biomarker monitoring aiming to develop the first non-invasive glucose monitoring wearable, is thrilled to announce significant technological milestones and a successful kick-off of its Series A.
Read More
